NCT00465218View on ClinicalTrials.gov

Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2011

Conditions
Aortic Valve Disease
Interventions
PROCEDURE

Prophylaxis of Thrombosis after aortic valve replacement

Two standard prophylactic treatments of thrombosis within the first 3 months postsurgery currently used in our institution: a) daily dose of aspirin (325 mgs; b) daily dose of aspirin (81 mg) plus Warfarin for target INR 2.0-2.5

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

Sponsors

Collaborators (1)

Edwards Lifesciences
All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

Ottawa Heart Institute Research Corporation

OTHER